Related Experiment Video

Updated: Jun 18, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer

B Y Ahn1, D L N Trinh, L D Zajchowski

  • 1Department of Biochemistry, University of Calgary, Calgary, Alberta, Canada.

Oncogene
|November 26, 2009
PubMed

Insights

The tumor suppressor Tid1 protein facilitates p53

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The p53 protein is a critical tumor suppressor involved in apoptosis induction.
  • A transcription-independent mitochondrial pathway for p53-mediated apoptosis exists, but its regulation is unclear.
  • Hypoxia is a condition that can influence cellular stress responses and apoptosis.

Purpose of the Study:

  • To elucidate the mechanism regulating p53 translocation to mitochondria.
  • To identify factors involved in the transcription-independent mitochondrial apoptosis pathway.
  • To explore the therapeutic potential of targeting this pathway in cancer.

Main Methods:

  • Investigated the interaction between Tid1 and p53 under hypoxic conditions.
  • Assessed the role of Tid1 in p53 mitochondrial translocation and apoptosis.
  • Utilized cancer cell lines expressing wild-type and mutant p53 isoforms.

Main Results:

  • Tid1 forms a complex with p53 under hypoxia, directing p53 to mitochondria and initiating apoptosis.
  • Loss of Tid1 inhibits p53 mitochondrial translocation and apoptosis; Tid1 overexpression promotes it.
  • Tid1's mitochondrial signal sequence and DnaJ domain are essential for p53-Tid1 complex translocation.
  • Tid1 overexpression restores mitochondrial localization and pro-apoptotic activity in mutant p53 cancer cells.

Conclusions:

  • Tid1 is a novel regulator of p53-mediated apoptosis via mitochondrial translocation.
  • Therapies enhancing Tid1 function could promote p53 mitochondrial localization and apoptosis in cancer.
  • Targeting the Tid1-p53 interaction offers a potential therapeutic strategy for various cancers.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.